a photo of a scientist made up of smaller photos of hplc work in the lab

thermo-july-ppl-1800x900

LC biopharma environmental food and beverage compendium

thermo-cover-3

thermo-header-3

Thermo Fisher Scientific

Develop and establish workflows with more efficient use of resources

Overcome Your Lab&#39;s Resource Limitations

Whitepaper

Gene therapy concept. Medical technology. Medtech.

istock-1302573302-1800x900

Flexible and scalable nonviral delivery for cGMP cell therapy processing

thermo-cover-5-1

Figure 3. Gating strategy for the Attune NxT Flow Cytometer.

2023-04-21-10-30-45

Figure 5. Gene editing efficiency. The dark blue bar represents the percent of cells expressing the integrated CAR sequence (knock-in), light blue represents knockout, and grey represents the unedited or wild type population

2023-04-21-10-34-40

Figure 4. Cell viability 72 hours post-electroporation in the CTS Xenon system.

2023-04-21-10-31-14

Figure 6. Phenotypic data post-electroporation. The dark blue bar represents CD4? cells, the light blue bar represents CD8? cells, and the grey bar represents either double positive or double negative CD4/8 cells. Below the bar charts is phenotypic characterization before activation, electroporation, and culture

Figure 1. Autologous T cell therapy workflow.

2023-04-21-10-25-38

Figure 2. Experimental conditions and electroporation parameters.

Scale and Optimize Your Cell Therapy Processing

two scientists in a clinical lab using a cell therapy system

thermo-cell-therapy-ppl-1-june-2022-1800x900

Large-Scale Nonviral Delivery for Cell Therapy

thermo-header-4-1

thermo-cover-4-1

Graphical depiction of a user-generated electroporation pulse profile.

screenshot-2023-04-21-152031

The effects of voltage, pulse width, and pulse number on transfection efficiency and post-electroporation viability as determined by design of experiment (DOE).

Viability in CAR T cells. Cells were assessed for viability after 72 hours using Trypan Blue Solution. For the three donors, cell viability on the CTS Xenon system ranged from 64.6% to 83.6%.

screenshot-2023-04-21-152328

Allowable electroporation parameters based on power and temperature limits of the instrument and chamber.

screenshot-2023-04-21-152113

Knockout and knock-in performance in CAR T cells. Cells were characterized after 72 hours as untransfected (TCR??+, gray), knocked out but not knocked in (TCR??–CAR–, light blue), or as successfully knocked out and knocked in (TCR??–CAR+, dark blue). Across all donors, successful knock-in percentages on the CTS Xenon system ranged from 21.9% to 45.6%, exceeding the values on the Neon system.

screenshot-2023-04-21-152231

Products that meet your need at every step of the workflow, from research through commercial manufacturing

screenshot-2023-04-21-152505

Preservation of CD4 vs. CD8 T cell ratio. CD4 and CD8 T cells were identified by flow cytometry. Non-electroporated cells (condition 0) were gated on live, single, and untransfected (TCR??+ cells), while electroporated cells were gated on live, single, and knocked out (TCR??– cells). Proportions of CD4 (dark blue) and CD8 (light blue) T cells remained largely consistent between non-electroporated cells and cells electroporated with the Neon system (100 ?L) and with the CTS Xenon system (1 and 9 mL).

screenshot-2023-04-21-152412

Large-scale nonviral delivery for cell therapy

Flexible Solutions that Facilitate Scale-Up&nbsp;

Genetic engineering concept. Medical science. Scientific Laboratory.

istock-1209892070-1800x900

Automated PBMC isolation and T cell wash and concentration

thermo-cover-2-1

june22-infocus-eppendorf-image2-1800x900

Figure 1. Simplified cell therapy workflow.

Figure 2. The CTS Rotea Counterflow Centrifugation System.

Figure 3. PBMC isolation using the CTS Rotea system. (A) Viability and recovery of PBMCs and (B) relative proportions of cell types present in an unprocessed Leukopak bag and after PBMC isolation.

figure3

Figure 6. Average recovery and viability for two T cell wash and concentrate runs with an input of 5 x 10? cells.

screenshot-2023-04-21-091707

Table 3. T cell wash and concentrate protocol.

Figure 4. T cell expansion. (A) Expansion of T cells isolated using the CTS Rotea system and a density gradient medium. (B) Characterization of the expanded T cells isolated using the CTS Rotea system and a density gradient medium.

screenshot-2023-04-21-091321

Figure 7. T cell washing and concentration. (A) T cell recovery and viability averaged over ten T cell washing and concentration runs. (B) Flow cytometry after staining of CD4 and CD8, before and after the CTS Rotea system washing and concentration protocol. (C) CTS Rotea system operating software with a chamber of T cells in a fluidized bed.

screenshot-2023-04-21-091743

Figure 5. Recovery and viability for T cell washing and concentration with 5 mL, 10 mL, and 20 mL output volumes.

screenshot-2023-04-21-091532

Improve Your Process and Manufacturing in Cell and Gene Therapy

cartoon scientists with lab equipment standing with plants and dna helix

istock-1207056635-1800x900

A Closed Cell-Processing System for Cell Therapy manufacturing

thermo-header-1-1

thermo-cover-1-1

Processing times and instrument specifications chart

screenshot-2023-04-21-151151

What the CTS Rotea system does at each step

Cell separation, concentration, washing, and more

Are You Looking to Improve Your Closed Cell Processing?

a cover photo of the vaccine research and development resource guide ebook

cover-mockup

a photo of the cover of the vaccine development ebook

withcover-1800x900-4

Sartorius

Lab Manager

Streamlining Vaccine Research and Development

Resource Guide

Two lab technicians working at a fume hood.

llo-1

Lab technician placing sample inside of a bag.

llo-3

Lab technician loading samples into a centrifuge.

llo-2

llo-4

A closeup of the top of a building on the Duke University School of Medicine–RTP Campus

may22-llo-1800x900-v2

Managers and staff from Duke University&rsquo; Moody Lab learned many lessons from starting a COVID-19 testing program and relocating during the COVID-19 pandemic 

Research Lab Shifts Focus, Moves to New Lab Space During Pandemic

Labs Less Ordinary

A graph showing the growth of the global genomics market from 2021 to 2026

may22-cover-genomics-infographic-1

The projected global market for genomics from 2021 to 2026

may22-cover-genomics-graph1-1

An infographic showing various next-generation sequencing choices and comparing their source, cost, and speed

may22-cover-genomics-1800x900-1

Genetic sequencing identifies overlooked approaches to therapy and treatment

Genomics Brings Precision to Medicine

Insights

A man riding a bike in a bike race for which he will need to take tramadol for his acute pain

thermo-april-ppl-1800x900

Fully automated dried spot analysis for the rapid quantitation of tramadol and its metabolites in various matrices

thermo-dried-cover

march-2022-1800x900

Rapid quantitation of tramadol and its metabolites

Fully Automate Your Dry Spot Sampling and Analysis

43844-lm-call-for-speakers-1800x900

Call for Speakers for Lab Manager's virtual events and conferences

Lab Manager seeks expert speakers for upcoming virtual conferences

Call for Speakers - Lab Manager Digital Summits

Digital Event

october-2025-turning-safety-principles-into-daily-practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Turning Safety Principles Into Daily Practice

End-to-end workflow from liquid biopsy sample to data analysis

figure1

The Agilent Avida Duo workflow enables the detection of DNA variants and methylation markers from the same sample input, with a fast turnaround time. 

figure-2

Initiate your analysis from FASTQ files from LBx or methylation samples

qc-comp

somamethyl-comp

filter-comp

curate-comp

reporting

End-to-end workflow from liquid biopsy sample to data analysis. 

figure-1-8-x-2-938-cropped

figure-2-8-x-3-291-cropped

Scientist holding up a blood vial with an illustration of DNA

86645-lm-agilent-article-socials-av-2400-x-1200

Agilent-logo

Agilent Technologies

Multiomic Insights from Liquid Biopsy with Agilent Avida and SeqOne Platform

mockup

1800x900-thumbnail

A team of female pharmacists in the production laboratory uses a high-resolution liquid chromatography device or HPLC SYSTEM to analyze and prepare a new product.

2400x1200-heroimage

perkinelmer-swp-full-color

PerkinElmer

sciex-logo-notag-black

SCIEX

Maximizing the Performance and Lifespan of Analytical Equipment

Rusty Bishop, PhD, chief commercial officer at TubeWriter.

rusty-bishop-2023-headshot-3

Cryovials with orange caps in a green rack surrounded by vapor, illustrating cold-storage sample handling and durable labeling in modern laboratory workflows.

Clinical

Overcome Your Lab's Resource Limitations